Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Sep 13, 2010 5:22pm

368 Views

Post# 17442929

RE: RE: End of Market Manipulation

Sharkfood, I am glad that you are protecting investors from pumpers but I am surprised that you do not suspect that manipulators will use the Board to dump on the stock and management. Your view of the Board is a ying with no yang. My mistake was to underestimate the influence of the Board. It is critical to running the con of a depressed stock price.

I would also like to clarify that I am not trying to put my back out through self congratulation. My purpose is to taunt the manipulators. I can wave a red flag like a bull fighter while they take it on the nose. Doug Ball is presenting tomorrow in NY. I hope the presentation throughs more onto the fire. It starts at 10:25.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario